NEW YORK, Jan. 07, 2026 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), today announced that Michael S. Weiss, the Company’s Chairman and Chief Executive Officer, will present at the 44 th ...

TG Therapeutics, Inc. has announced a conference call scheduled for May 5, 2025, at 8:30 AM ET to discuss its first quarter financial results and provide a business outlook for the remainder of 2025.

NEW YORK, April 30, 2024 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (TGTX), today announced that a conference call will be held tomorrow, Wednesday, May 1, 2024, at 8:30 AM ET to discuss results for ...

NEW YORK, June 06, 2025 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX) today announced that Michael S. Weiss, the Company’s Chairman and Chief Executive Officer, will participate in the ...

HEMPSTEAD, N.Y.--(BUSINESS WIRE)--Members of the transgender community gathered en masse for the first time since the start of the coronavirus disease 2019 (COVID-19) pandemic to connect on several ...

Combination of TGR-1202 (umbralisib) plus ibrutinib appears well tolerated with no Grade 3/4 transaminitis, pneumonitis, diarrhea, or colitis observed, with longest patients on study 29.5+ months 94% ...

Last week, Manhattan Institute senior fellow Chris Rufo broke a shocking story out of the School District of Philadelphia. According to videos obtained by Rufo, the school district encouraged teachers ...

TG Therapeutics expects fourth-quarter BRIUMVI net product revenue in the U.S. to be $103.6 million. TG Therapeutics says it expects to report a 2024 year-end cash position of approximately $310 ...

Republican leaders from Congress expressed "serious concern" with the Mountain West Conference about transgender women participating in women's sports. Thirteen officials signed a letter to Mountain ...

Gender Odyssey, Seattle’s annual transgender conference, is in full swing with thousands of therapists, families, and advocates coming together in what is predicted to be the largest of the yearly ...

NEW YORK, Oct. 31, 2025 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (TGTX), today announced that a conference call will be held, Monday, November 3, 2025, at 8:30 AM ET to discuss results for the third ...